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Evidence of the presence of nucleic 
acids and β-glucan in the matrix 
of non-typeable Haemophilus 
influenzae in vitro biofilms
Mirian Domenech1,2, Elena Pedrero-Vega1, Alicia Prieto3 & Ernesto García1,2
Non-typeable Haemophilus influenzae (NTHi) is a Gram-negative bacterium that frequently colonizes 
the human nasopharynx; it is a common cause of chronic and recurrent otitis media in children and 
of exacerbations of chronic obstructive pulmonary disease. To date, no exopolysaccharide clearly 
contributing to NTHi biofilms has been identified. Consequently, there is some debate as to whether 
NTHi forms biofilms during colonization and infection. The present work shows that NTHi can form 
biofilms in vitro, producing an extracellular matrix composed of proteins, nucleic acids, and a β-glucan. 
Extracellular DNA, visualized by immunostaining and using fluorochromes, is an important component 
of this matrix and appears to be essential in biofilm maintenance. Extracellular RNA appears to be 
required only in the first steps of biofilm formation. Evidence of a matrix polysaccharide was obtained 
by staining with Calcofluor white M2R and by disaggregating biofilms with cellulase. Using strain 
54997, residues of Glcp(1→4) in the NTHi biofilm were confirmed by gas-liquid chromatography-mass 
spectrometry. Evidence that N-acetyl-L-cysteine shows notable killing activity towards in vitro NTHi 
biofilm-forming bacteria is also provided.
Non-typeable (non-encapsulated) Haemophilus influenzae (NTHi) is an opportunistic pathogen that colonizes 
the nasopharynx of some 80% of humans1. Colonization promotes the development of disease and produces 
bacterial reservoirs facilitating person-to-person transmission. NTHi is the main bacterial cause of chronic otitis 
media (OM) with effusion, recurrent acute OM, and acute OM with treatment failure2. In addition, NTHi is one 
of the main causal agents of upper and lower respiratory tract disease, such as sinusitis, conjunctivitis, and exac-
erbations of cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD)3. Indeed, chronic infection 
with NTHi contributes to the progression of COPD and accounts for approximately 20–30% of all exacerbation 
episodes. It should be noted that, by 2020, COPD is projected to rank fifth in the global burden of disease4. In 
addition, NTHi infections frequently become chronic and recurrent; up to 30% of children who experience at 
least one episode of OM, re-experience three or more episodes before three years of age5.
Chronicity and recurrence are characteristic of diseases produced by biofilm-forming microorganisms6; bac-
terial strains isolated from patients with persistent infections are usually biofilm producers7. A biofilm is defined 
as layers of cells of microorganisms adhered to the surface of an organic or inorganic substrate and embedded in 
an extracellular matrix8. This matrix consists of a mixture of biopolymers (extracellular polymeric substances or 
EPS) synthesized largely by the biofilm-producing microorganisms themselves. In most cases, the formation of 
biofilms is controlled by a regulatory switch, and the transition from planktonic to biofilm growth involves the 
production of an extracellular polysaccharide plus other macromolecules9. It has been reported that NTHi strains 
isolated from patients with CF, OM or COPD are prone to form biofilms in vitro and in vivo10,11. In the past, some 
have expressed doubts about the relevance of NTHi biofilms in disease12, although evidence exists that NTHi 
can grow in an aggregate form that is consistent with a biofilm and that this form of growth affects virulence9,10. 
Whether NTHi is truly capable of biofilm formation, however, is a matter of debate13. Firstly, while a number of 
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studies have reported quorum sensing in NTHi, issues exist regarding the relationship between this and biofilm 
formation in these bacteria; for example, NTHi mutants for several quorum sensing genes can still form sup-
posed biofilms14. Secondly, while in vivo studies suggest extracellular DNA (eDNA) to be a major element of 
NTHi biofilms15, and while treatment with DNase I increases the susceptibility of the NTHi present to certain 
antibiotics16, it is debatable whether this eDNA (or any EPS present) is of bacterial or host origin (or both)13. 
Even if the eDNA were bacterial, it could be the product of autolysis. The purported existence in the matrix of 
in vitro biofilm-specific proteins has, however, been reported providing some evidence that biofilm formation 
does occur17.
In addition to proteins and eDNA, two components of NTHi lipooligosaccharides (LOS) have been reported 
important in biofilm formation: sialic acid (Neu5Ac) and phosphorylcholine14. Since NTHi is auxotroph for 
Neu5Ac, this compound must be taken up from the host, and mutants deficient in Neu5Ac incorporation into 
LOS are reported impaired in their capacity to form biofilms in vitro18. Moreover, a direct relationship between 
the phosphorylcholine content of the LOS and the capacity to form biofilms has been reported19,20, although this 
finding may have been the result of the particular method used to test biofilm formation, i.e., continuous flow or 
static systems21. In most microorganisms, the transition from planktonic to biofilm growth involves production 
of an extracellular polysaccharide22. However, there has yet to be an exopolysaccharide identified that clearly 
contributes to NTHi biofilms23. Thus, the question of whether NTHi really forms biofilms has remained partly 
unanswered13. The present work goes some way to settling this issue by providing evidence of substantial amounts 
of bacterial eDNA, plus a hitherto unknown extracellular β -glucan polysaccharide, among the EPS components 
of in vitro NTHI biofilms.
Results
Biofilm formation capacity of different NTHi strains. The biofilm-forming capacity of four NTHi 
strains, i.e., 54997, 86–028NP, 375 Δ opsX and Rd KW20, was examined. It has been reported that strain NTHi 375 
Δ opsX (a strain deficient in the heptosyltransferase I for lipopolysaccharide biosynthesis) forms biofilms not signif-
icantly different to those produced by the wild-type strain20. In addition, the genomes of strains 375 and 86–028NP 
share notable synteny (although they also show distinct genome rearrangements) (Supplementary Fig. S1). 
This agrees with the finding that the sequence types (ST) of these strains (see Methods) share 5 of the 7 alleles 
used in multilocus sequence typing.
It was observed here that all strains formed supposed biofilms in both C medium supplemented with yeast 
extract, haemin and NAD [s(C+ Y)] (especially well) and in supplemented brain-heart infusion (sBHI) (Fig. 1). 
The s(C+ Y) medium was developed in our laboratory during preliminary experiments aimed at producing 
Streptococcus pneumoniae–NTHi mixed biofilms (unpublished results). Moreover, this medium has the additional 
advantage that it does not produce a detectable background after crystal violet (CV) staining, unlike sBHI. In both 
media, however, strains 54997 and Rd KW20 were the best and worst producers respectively. For this reason, 
strain 54997 was used for most of the following experiments.
Extracellular proteins and nucleic acids. Exposure to proteolytic enzymes led to the dispersal of the 
NTHi biofilms indicating their matrix to contain proteins important in their maintenance (Fig. 2a,b). Treatment 
of the biofilms with DNase I confirmed eDNA to be present in the matrix, and to be important in its preservation 
(Fig. 2c). Nuclease treatment of growing biofilms strongly suggested the importance of extracellular RNA (but not 
DNA) in biofilm formation (Fig. 2e,f). However, once a biofilm formed, it appeared that extracellular RNA was 
not necessary to ensure its continued integrity (Fig. 2d).
In situ staining with DDAO (7-hydroxy-9H-[1,3-dichloro-9,9-dimethylacridin-2-one]) revealed abundant, 
apparently cell-associated eDNA in a 6 h-old biofilm formed by NTHi strain 54997 in s(C+ Y) medium (Fig. 3a–c). 
Moreover, immunostaining with anti-double-stranded (ds) DNA monoclonal antibodies revealed a network-like 
structure consisting of long DNA strands with numerous bacteria at the top of the biofilm (Fig. 3d–f,j). At the 
bottom, only small areas of what appeared to be compacted eDNA were seen (Fig. 3g–i). Planktonic cultures of 
strain 54997 incubated with DDAO, or immunostained with anti-dsDNA antibodies, showed no DNA-related 
fluorescence (data not shown).
Polysaccharide component of the NTHi biofilm matrix. To determine whether matrix polysaccha-
ride(s) is required for biofilm preservation, sodium metaperiodate — a mild oxidant for converting the hydroxyl 
groups [cis-glycol] in carbohydrates to reactive aldehyde groups — was added to a biofilm formed by strain 
54997. Notable destruction of NTHi biofilms was observed when treated with 40 μ g mL–1 of this compound 
(Supplementary Fig. S2).
In a first attempt to identify the sugar components of the NTHi matrix glycan, five different Alexa-conjugated 
lectins were used (see Methods). Positive labelling was observed only with concanavalin A (ConA) (Fig. 4). This 
stained the biofilms formed by NTHi 54997, 86–028NP and 375 Δ opsX, but not that formed by strain Rd KW20 
(Fig. 4f–i). Labelling intensity varied greatly among strains, suggesting that the biosynthesis of the putative matrix 
polysaccharide may be strain-dependent. Interestingly, incubation of ConA with 80 mg mL–1 of either D(+ )glu-
cose (Glc) or D(+ )mannose (Man) before addition to the biofilms prevented their labelling, especially when 
D(+) Man was used (Fig. 5). Planktonically grown cells of all these strains (again with the exception of Rd KW20) 
also stained with ConA (Fig. 4j and data not shown).
The observation that ConA did not label the biofilm formed by NTHi Rd KW20 suggested the possibility that 
ConA-labelling might be related to the presence/absence of a pair of high molecular weight (HMW) adhesins 
described in a number of NTHi isolates24. These proteins are synthesized by ≈ 60% of NTHi isolates, and 90% 
of these possess two HMW adhesin-coding genes25. Interestingly, hmw genes are present in strains 86–028NP26 
and 37527, but absent in strain Rd KW20. The adhesin HMW1 (and presumably also HMW2) of strain 12 (also 
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named R2846; Acc. No. CP002276) is a glycoprotein in which 31 asparagine residues are N-glycosylated28. Based 
on chemical analysis it has been shown that the carbohydrate of HMW1 contains galactose (Gal), Glc and Man29. 
In the present work, when the amino acid sequence of the HMW1 adhesins of the sequenced strains were aligned 
and compared to that of strain 12, in which the N-glycosylated asparagine residues were originally identified, 
several changes were found (Supplementary Fig. S3). Five and nine asparagine residues present in strain 12 
were not present in strains 86–028NP and 375 respectively. Of these, two and five changes, respectively, were 
non-conservative substitutions.
Calcofluor white M2R (CW) was used to check for the presence of a glycan component in the NTHi matrix. 
Biofilm-growing NTHi cells (Fig. 6), but not planktonic cells (not shown), were able to bind CW in significant 
amounts, and most of the CW-stained material appeared to be cell-associated. Interestingly, the biofilm formed 
by NTHi 375 Δ opsX, a strain lacking all core sugars of the LOS, also stained with CW (Fig. 6g), which strongly 
suggests that CW labelling of NTHi biofilms is largely unrelated to the presence of LOS components. Since CW 
is known to bind to β -polysaccharides such as chitin and cellulose30, these results suggest the NTHi biofilm to 
be composed of aggregates of microbial cells encased in an extracellular polysaccharide matrix that contains 
(at least) β -linked D-glycopyranosyl units. The specificity of CW labelling was checked by pre-incubating the 
compound with either pullulan (an α -glucan) (Fig. 7d–f) or cellulose (a β -glucan) (Fig. 7g–i). Only cellulose was 
able to inhibit the binding of CW, as indicated by the loss of fluorescence.
To further investigate the presence of a polysaccharide component in the matrix, NTHi 54997 biofilms were 
incubated with cellulase. This glycolytic enzyme was very effective in killing the bacteria and dispersing the NTHi 
biofilms, as determined by BacLight LIVE/DEAD staining (Supplementary Fig. S4). A direct relationship between 
Figure 1. Biofilm formation capacity of four NTHi strains. Bacteria were incubated for 6 h at 37 °C in a 5% 
CO2 atmosphere to allow biofilm development. (a) CLSM images of the NTHi strains grown in s(C+ Y) and 
sBHI media. The cells in the biofilms were stained with SYTO 9. Horizontal reconstructions of 55 scans  
(x–y plane) are shown. In all images the scale bar = 25 μ m. (b) For biofilm formation, NTHi cells were grown 
in s(C+ Y) medium on polystyrene microtiter plates and stained with CV. Grey and black bars indicate growth 
(adherent plus non-adherent cells) and biofilm formation respectively. *P < 0.001 compared to the biofilm 
formed by strain 54997. The results are the average of three independent experiments each performed in 
triplicate.
www.nature.com/scientificreports/
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bacterial killing and biofilm disaggregation could not be established since, at least in some cases, biofilm-growing 
bacteria may be enzymatically killed without any appreciable biofilm dispersal31.
Chemical analysis of the extracellular polysaccharide. Since, under the present experimen-
tal conditions, NTHi 54997 was the best biofilm former (Fig. 1), the extracellular polysaccharide synthesized 
by biofilm-growing cells of this strain was analyzed by chemical methods. Both the alkali-soluble (AS) and 
-insoluble (AI) fractions of the biofilm (AS-B and AI-B respectively) were subjected to acid hydrolysis to release 
the monosaccharides. The same procedure was performed to investigate the planktonic component of the biofilm 
(i.e., the non-adherent cells in biofilm culture [BP], and planktonic culture [P]). Irrespective of their origin, only 
small amounts of carbohydrates (< 2% of the dry weight) were found in the AS fractions (data not shown) so were 
studied no further. In contrast, the major monosaccharide component of the AI-B and AI-BP fractions was Glc 
(up to 40% and 20%, respectively); only minor amounts (4.5% and < 1%, respectively) of Man and glucosamine 
(< 0.5% in the AI-B fraction) were detected. No putative LOS components were detected. The AI-P fraction con-
tained 4–5% Man and only < 1% Glc (data not shown). The Man component found in the AI fraction may originate 
from the yeast extract component of the growth medium — s(C+ Y) — which contains mannans in large amounts.
Methylation analysis of AI-B and AI-BP showed both fractions to contain the same type of polymer — 
although it was much more abundant in adherent, biofilm-forming cells (see above) — and to be mainly com-
posed of linear → 4)-Glcp-(1→ units (Fig. 8). This glucan appears to be slightly branched, as deduced from the 
presence of peaks identified as terminal glucopyranose residues (Glcp-(1→ ) and branching points at positions 
O-3 and/or O-6 on the main chain (Fig. 8). Alkali insolubility32, labelling with CW and biofilm destruction with 
cellulase indicated these units to be connected by β -linkages. Thus, the polysaccharide must be a β -(1 → 4)-glucan.
Figure 2. Inhibition and dispersal of NTHi biofilms with proteases and nucleases. Panels a–d correspond 
to dispersal assays. After biofilm development (6 h at 37 °C under 5% CO2), non-adherent cells were removed, 
enzymes at the indicated concentrations were added and incubation allowed for an additional 1 h at 37 °C 
under 5% CO2 before staining with CV to quantify biofilm formation. Panels e and f correspond to inhibition 
assays. NTHi 54997 was grown overnight at 37 °C under 5% CO2 to an A550 value of 0.5 (corresponding to the 
late exponential phase of growth) in s(C+ Y) medium, centrifuged, and adjusted to an A550 of 0.6 with fresh 
medium. The cell suspension was then diluted 100-fold, and 200 μ l aliquots were distributed in the wells of 
a microtiter plate, which was then incubated for 6 h at 37 °C under 5% CO2 with DNase I, or RNase at the 
indicated concentrations. In all panels, grey and black bars indicate growth (adherent plus non-adherent cells) 
and biofilm formation respectively. *P < 0.05 and **P < 0.001 compared with the untreated control.
www.nature.com/scientificreports/
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Prevention of biofilm formation and therapy. Drug ‘repurposing’ (or ‘reprofiling’) appears a prom-
ising possibility for speeding up drug discovery, reducing failure rates and the associated costs33. In the present 
work, the mucolytic compound N-acetyl-L-cysteine (NAC) and the well-known sugar substitute xylitol were 
examined as candidates for use in future strategies aimed at preventing and improving the management of upper 
Figure 3. CLSM evidence of eDNA in NTHi biofilms. A biofilm of NTHi 54997 was stained with a 
combination of SYTO 9 (a, green) and DDAO (b, blue), or with a combination of SYTO 59 (d and g red) and 
anti-dsDNA mouse monoclonal antibody, followed by Alexa Fluor 488-labelled goat anti-mouse IgG (dsDNA 
mAb) (e and h) green). Images d–f and g–i correspond, respectively, to the top and bottom parts of the biofilm. 
Images (c,f and i) are mergers of the two previous channels and represent maximum projections of a series of 
x–y sections. Scale bars = 25 μ m. (j) Enlargement of the area marked with a rectangle in (f). Yellow indicates co-
localisation of the two fluorophores.
Figure 4. Staining of NTHi biofilms with ConA-Alexa fluor 647. NTHi biofilm matrix stained with SYTO 
9 (green fluorescence) (a–d) and ConA lectin (pink fluorescence) (f–i). (e,j) Planktonically-grown 54997 cells 
stained with SYTO 9 and ConA. Scale bars = 25 μ m.
www.nature.com/scientificreports/
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and lower respiratory tract diseases caused by biofilm-forming NTHi. Figure 9a shows that, in the present work, 
NAC inhibited biofilm formation by NTHi 54997, and caused the death of ≥ 95% of bacteria in the biofilm when 
used at concentrations of ≥ 0.5 mg mL–1 (Fig. 9b,d) (well below the minimum inhibitory concentration [MIC] of 
2.5 mg mL–1; see Methods). Besides, a significant reduction in growth and in biofilm formation by NTHi 54997 
was observed when xylitol was used at concentrations of ≥ 10 mg mL–1 (Fig. 9c).
Discussion
The ability of bacteria to produce biofilms appears to be governed by many genes and to be under tight regulation; 
certainly, different NTHi isolates show different biofilm-forming capacity34 (Fig. 1), perhaps a consequence of 
the well-known genetic heterogeneity of NTHi populations35. Proteins are important components of the bio-
film EPS, and different experimental approaches have been employed to try to identify NTHi biofilm-specific 
proteins. Several proteins are present among the EPS of in vitro NTHi biofilms, namely, the adhesins Hap and 
HMW1/HMW2, and the IgA1 protease36. The requirement for the surface protein Hap in biofilm formation has, 
however, recently been questioned37. In an independent study involving liquid chromatography coupled with 
tandem mass spectrometry, more than 200 proteins were identified in the extracellular matrix of NTHi biofilms 
formed on Millipore filters38. Unfortunately, the presence of lysed-cell components among the samples analyzed 
could not be ruled out38. More recently, mild sonication was used to extract the EPS of in vitro NTHi biofilms, 
and chemical analysis, nuclear magnetic resonance and Fourier transformed infrared spectroscopy used to reveal 
the presence of proteins (18 of which were proposed potential biofilm-specific proteins), polysaccharide(s) and 
DNA among them17. Whether only intact bacteria were the source of these macromolecules could not, however, 
Figure 5. Inhibition of ConA-Alexa fluor 647 staining by monosaccharides. Biofilm of strain 54997 stained 
with SYTO 9 (a; green fluorescence) and ConA lectin (b; pink fluorescence). A merger of the above two 
channels is shown in (c). (d–i) As in (a–c) but where ConA was incubated with 80 mg mL‒1 of D(+ )Glc (d–f) or 
D(+ )Man (g–i) before staining the biofilm. Scale bars = 25 μ m.
www.nature.com/scientificreports/
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be conclusively demonstrated. No protein identification was attempted in the present study, but treatment with 
either proteinase K or trypsin fully confirmed proteins to be required for the maintenance of NTHi biofilms.
Nucleic acids are also important components of NTHi biofilm matrices. Extracellular RNA appears to be 
required for the initial attachment of — but not the maintenance of — a biofilm. Certainly, the presence of RNase 
led to a significant reduction in biofilm development (Fig. 2f), but had no effect on already formed biofilms 
(Fig. 2d). To our knowledge, the requirement of extracellular RNA for biofilm formation has never before been 
reported, although this result may not be representative of all NTHi clinical isolates. Although the release of RNA 
to the medium is normally attributed to autolytic processes, Mycobacterium tuberculosis and Escherichia coli do 
secrete small RNA fragments into the culture medium in the absence of detectable autolysis39,40. In contrast, the 
importance of eDNA in both the establishment and maintenance of bacterial biofilms is well known.
The eDNA of NTHi and other bacterial biofilms can be visualized under the confocal laser scan-
ning microscope (CLSM) using fluorescent, ds specific stains15 plus propidium iodide, ethidium bromide, 
4′,6-diamidino-2-phenylindole (DAPI) or SYTO dyes. The sensitivity of the microscope must, however, be 
strongly increased, and good quality images can be hard to obtain41. Recently, DDAO has been shown very suita-
ble for selectively targeting eDNA given its enhanced fluorescent properties and since its molecular size prevents 
the stain from penetrating intact cell membranes42. In the present work, staining with DDAO showed eDNA to be 
distributed throughout the biofilm but, when anti-dsDNA antibodies were present, long filaments of eDNA with 
attached bacteria were evident mostly in the upper part of the biofilm (Fig. 3). Since most were actively growing 
NTHi cells, it would appear unlikely that eDNA fibres are formed exclusively via autolysis. Rather, some kind of 
programmed release, involving a biofilm-specific secretion process, might be at work, although further research 
is needed to test this hypothesis. Previous studies have shown that eDNA binds extracellular proteins such as PilA 
(the type IV pilin protein)15 and the bacterial DNABII family of proteins (also known as histone-like proteins or 
Hlps)43. Recent results from our laboratory have shown that the choline-binding proteins of S. pneumoniae have 
the unexpected capacity to strongly bind DNA through electrostatic interactions; they may therefore be impor-
tant in the early stages of biofilm formation31,44. This might also be true for other bacteria.
It is generally accepted that carbohydrates are important components of biofilm matrices45. The biosynthe-
sis of alginate by species of Pseudomonas and Azotobacter, and of poly-β -1,6-N-acetylglucosamine by many 
Gram-positive and Gram-negative bacteria, has been quite well studied22. However, no exopolysaccharide has 
been identified that clearly contributes to NTHi biofilms23. Sodium metaperiodate has been extensively used to 
test for the presence of carbohydrates in EPS46. This compound induced disaggregation of NTHi biofilms strongly 
suggesting that they contain a glycan. Moreover, with the notable exception of strain Rd KW20, the incubation of 
biofilms with ConA revealed the presence of accessible α -Man and/or Glc residues. Although direct evidence is 
lacking, the absence of the two genes coding for the HMW adhesins (glycoproteins) in strain Rd KW20 suggests 
that ConA binds to the N-linked glycan of HMW. The differences seen in ConA-labelling between the different 
biofilms may be due to variation in the number of glycosylated Asn residues and/or to variations in the expression 
of hmw genes, which is known to be modulated by phase variation47. In any event, as planktonically grown cells 
of all the NTHi strains tested here (with the exception of Rd KW20) also stained with ConA, the ConA-labelled 
carbohydrate(s) appears to be not biofilm-specific.
Figure 6. Calcofluor (CW) staining of NTHi biofilms. (a–d) a merger of biofilms of the four NTHi strains 
stained with SYTO 9 (green fluorescence) and CW (blue fluorescence). In panels (e–h) only the CW staining is 
shown. Scale bars = 25 μ m.
www.nature.com/scientificreports/
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The literature contains no report of any exopolysaccharide in the matrix of NTHi biofilms23; the CW staining 
results provide the first experimental evidence that a cellulose-like β -polysaccharide is present (Fig. 6). Moreover, 
disaggregation by cellulase, and the chemical analysis of the alkali-insoluble fraction of strain 53997 biofilms, pro-
vided compelling evidence of the presence of a cellulose-like carbohydrate with β -(1→ 4) linked glucosyl residues 
(and possibly other monosaccharides as putative side chain substituents) among the EPS (Fig. 8). This glucan 
would appear completely unrelated to glycogen (an α -glucan), which is overproduced when NTHi biofilms are 
treated with sub-inhibitory concentrations of β -lactam antibiotics48.
Cellulose is the most abundant biopolymer on Earth, and is synthesized by bacteria, protists, algae, plants 
and even by some tunicates. Members of the classes α -, β - and γ -Proteobacteria synthesize cellulose as an EPS 
component, and it plays important roles in biofilm formation and maintenance49. However, cellulose production 
genes have not been found among the members of Pasteurellaceae; the present finding of a polysaccharide sim-
ilar to cellulose in NTHi biofilms was therefore totally unexpected. It has been shown, however, that Histophilus 
somni, a relative of H. influenzae, synthesizes an exopolysaccharide composed of a D-mannan polymer and with 
occasional Gal residues present on side chains during biofilm formation50, although the glycosyltrasferase(s) 
responsible for its synthesis has not been identified. Aggregatibacter actinomycetemcomitans, another member of 
Pasteurellaceae, also forms biofilms containing an extracellular homopolymer of N-acetylglucosamine residues in 
β (1 → 6) linkage that acts as an important virulence factor51.
A search of the CAZy database52 revealed the existence of up to 30 putative glycosyltransferase-coding 
genes in different NTHi genomes, most of them putatively involved in glycogen production or LOS biosynthe-
sis53. Interestingly, the putative glycosyltransferases LsgC, LsgE and LsgF of NTHi appear to be homologous 
(E value ≤ 10–15), respectively, to AmsD, AmsB and AmsE, proteins involved in the synthesis of amylovoran, 
the acidic exopolysaccharide of Erwinia amylovora54. These corresponding NTHi genes are part of the lsg locus 
(from HI_1695 to HI_1700 in the Rd KW20 chromosome) and are fully conserved across NTHi isolates. Further 
Figure 7. Specificity of Calcofluor (CW) staining. A biofilm of the NTHi 54997 strain stained with SYTO 9 
(a; green fluorescence) and CW (b; blue fluorescence). A merger of the above two channels is also shown (c). 
In panels (d–i) CW was incubated with pullulan (d–f) or cellulose (g–i) (at 25 mg mL–1 each), before staining. 
Scale bars = 25 μ m.
www.nature.com/scientificreports/
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studies are warranted to determine whether the lsg gene products play a role in the synthesis and/or transport of 
the biofilm-specific β -glucan described in this study.
One of the most important and persistent problems posed by biofilms is the tolerance bestowed upon the 
communities they house to antibiotic therapy and host defence mechanisms. To our knowledge, the literature 
contains only a few reports on the activity of antibiotics against NTHi biofilms; these have involved the use of 
single and multiple antibiotics such as quinolones, macrolides, aminoglycoside, penicillin and cephems55. The 
exposure of NTHi biofilms to sub-inhibitory concentrations of β -lactam antibiotics has been reported to pro-
duce a strain- and antibiotic-dependent increase in biofilm formation48. Certainly, the need for alternatives to 
antibiotic treatment is becoming ever clearer since bacteria in a biofilm can survive antibiotic concentrations up 
to 1000 fold those that would kill them when in a planktonic state56. Enzymes that degrade the biofilm matrix, 
inhibitors of quorum-sensing signals, anticoagulant agents, surfactants, and specific bacteriophages and their 
endolysins may all provide alternatives57–59. NAC, a thiol-containing antioxidant that disrupts disulphide bonds 
in mucus, has been clinically available for several decades and is used in the treatment of a variety of clinical 
conditions including chronic bronchitis, ototoxicity caused by certain anti-cancer (e.g., cisplatin) or antibacterial 
(e.g., aminoglycosides) drugs, and in acetaminophen (paracetamol) poisoning60. However, it also has antibacte-
rial properties, particularly against microorganisms (Gram-positive and Gram-negative) growing in biofilms61. 
Interestingly, NAC has been reported not only to inhibit the in vitro formation of S. pneumoniae biofilms, but also 
to disaggregate already formed biofilms62. The concentrations of NAC that inhibited and killed the bacteria of 
the NTHi biofilms are similar to those that are theoretically obtained in oropharyngeal secretions during normal 
oral NAC treatment with 200–600 mg tablets taken two or three times daily63. Higher doses (up to 2400 mg/day 
divided into two doses over 30 days) are also well tolerated and beneficial in patients with CF64. Moreover, if required, 
NAC can be administered directly into the middle ear. In fact, transtympanic injections of up to 20 mg mL–1  
NAC appear to be well tolerated in humans, as demonstrated in a recent clinical trial65.
The polyalcohol xylitol may have a variety of medical and pharmaceutical applications, including the treat-
ment and/or prevention of acute OM66,67 and viral respiratory diseases68. It is reported that xylitol evades micro-
bial resistance and can control infection both alone and in combination with other compounds. Moreover, it has 
been documented that xylitol has anti-adherent properties that may be relevant for fighting biofilm formation69. 
In the present in vitro system, xylitol was indeed capable of inhibiting the formation of NTHi biofilms, but at con-
centrations much higher than those required by NAC for an equivalent reduction (Fig. 9).
In conclusion, this study shows that, actively growing NTHi cells release eDNA (a major EPS component), 
and that the biofilm produced contains a hitherto unknown β -glucan. Together with our previous results31,44, plus 
Figure 8. GC-MS chromatograms showing the linkage types identified in the polysaccharides recovered 
from alkali-insoluble extracts of biofilms (AI-B) and their planktonic component (AI-BP). 
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those of other authors on pneumococcal biofilms70, the present findings pave the way for detailed in vitro studies 
on more complex pneumococcal–NTHi biofilms.
Methods
Bacterial strains, growth conditions, biofilm formation and susceptibility testing. Four NTHi 
strains were used: 1) 54997, isolated from a patient with acute OM11; 2) 86–028NP (ST33), recovered from the 
nasopharynx of a child with chronic OM26; 3) a Δ opsX mutant of strain 375 (ST3)27 that synthesizes a truncated 
LOS lacking all core sugars and exposing the 3-deoxy-α -D-manno-octulosonic acid attached to lipid A20; and 
4) Rd KW20 (ST47), a mutant of a serotype d strain, which completely lacks the entire capsule locus due to a 
deletion71. Unless otherwise stated, NTHi strains were grown at 37 °C in a 5% CO2 atmosphere in C+ Y medium31 
or brain-heart infusion (BHI) supplemented with 10 μ g mL–1 each of haemin and NAD, referred to as s(C+ Y) and 
sBHI respectively. Both media were supplemented with NAD and haemin to allow the growth of H. influenzae. 
When required, NTHi was grown on chocolate agar plates (bioMérieux).
For biofilm formation, NTHi strains were grown at 37 °C and under 5% CO2 in sBHI medium to an absorb-
ance at 550 nm (A550) of 0.5. They were then sedimented by centrifugation, resuspended in an equal volume of 
s(C+ Y) or sBHI, and diluted 100-fold. Inocula of 4–5 × 106 colony-forming units (CFU) mL−1 were dispensed 
into each well of Costar 3595 96-well polystyrene microtiter plates (Corning). Plates were incubated at 37 °C for 
5–6 h in a 5% CO2 atmosphere, and bacterial growth (adherent plus non-adherent bacteria) was determined by 
measuring the A595 using a VERSAmax microplate absorbance reader (Molecular Devices). Biofilm formation 
Figure 9. Inhibition of biofilm development in NTHi cultures in the presence of N-acetyl-L-cysteine (NAC) 
or xylitol. (a) Strain 54997 was distributed in the wells of a microtiter plate, which was then incubated for 6 h at 
37 °C under 5% CO2 in the presence of different concentrations of NAC. (b) Killing of NTHi 54997 cells growing 
as biofilms by incubation at 37 °C under 5% CO2 for 90 min with NAC at the indicated concentrations. (c) As 
in (a), but with xylitol instead of NAC. Biofilm formation was quantified by staining with CV. In panels a and c, 
grey and blackened bars indicate growth (adherent plus non-adherent cells) and biofilm formation respectively. 
Results represent the mean ± standard error of at least four independent experiments, each performed in 
triplicate. *P < 0.01 and **P < 0.001 compared with the control. (d) CLSM image of the viability of biofilm-
grown NTHi 54997 untreated (panels 1–3) or treated (panels 4–6) with 0.5 mg ml–1 of NAC for 90 min at 37 °C 
under 5% CO2. Cells in the biofilms were stained with the BacLight kit showing viable (green fluorescence) and 
non-viable (red fluorescence) bacteria. Images are horizontal three-dimensional reconstructions of 25 scans in 
the x–y plane. Scale bars = 25 μ m.
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was measured using a modified CV assay72. Fifty microlitres of a 1% solution of CV were added to each well. 
The plates were then incubated at room temperature for approximately 15 min, rinsed three times with 200 μ L of 
distilled water, and air dried. CV-stained biofilm formation was quantified by solubilizing the biofilm with 95% 
ethanol (200 μ L/well) and then determining the A595. For the inhibition of biofilm formation, the enzymes or 
antioxidants to be tested were added to the bacteria at the beginning of the incubation in the plates. For dispersal 
of biofilms, after biofilm formation for 6 h, non-attached cells were withdrawn, the enzymes or antioxidants were 
added and incubated for 1–1.5 h at 37 °C.
The susceptibility of NTHi isolates to antibacterial agents was determined using the broth microdilution 
method according to CLSI guidelines73. The MIC values for NAC and xylitol were identical (2.5 mg mL–1) (data 
not shown).
Microscopic observation of biofilms. For the observation of NTHi biofilms by CLSM, strains were 
grown on glass-bottomed dishes (WillCo-dish, WillCo Wells) for 5–6 h at 37 °C in a 5% CO2 atmosphere. 
Following incubation, the culture medium was removed and the biofilm rinsed with sterile water to remove 
non-adherent bacteria. The biofilms were then stained with DDAO (H6482, Invitrogen), anti-dsDNA antibody 
(ab27156, Abcam) (at 2–25 μ g mL–1 each), and SYTO 9 (10 μ M) (S34854, Invitrogen), SYTO 59 (10 μ M) (S11341, 
Invitrogen) and CW (50 μ g mL–1) (#18909, Sigma-Aldrich). When indicated, biofilms were stained with the bac-
terial viability BacLight kit (5 μ M) (L7007, Invitrogen). To tentatively identify the sugar components of the NTHi 
matrix glycan, Alexa-conjugated lectins, i.e., ConA (specific for α -Man and α /β -Glc), peanut agglutinin (PNA; 
specific for terminal residues of β -Gal, e.g., in Galβ -1,3-N-acetylgalactosamine [GalNAc] residues of N-glycans 
and glycolipids), soybean agglutinin (SBA; specific for GalNAc as in GalNAcα -1,3-Gal of O-linked glycopep-
tides), wheat germ agglutinin (WGA; specific for N-acetylglucosamine and Neu5Ac) and Helix pomatia agglu-
tinin (HPA; specific for α -GalNAc) were used74. The biofilms were stained with ConA-Alexa fluor 647 (C21421, 
Invitrogen), HPA-Alexa fluor 488 (L11271, Invitrogen), PNA-Alexa fluor 594 (L32459, Invitrogen), SBA-Alexa 
fluor 488 (L11272, Invitrogen) or WGA-Alexa fluor 488 (W11261, Invitrogen) at 5–25 μ g mL–1 each. All stain-
ing procedures involved incubation for 10–20 min at room temperature in the dark, except when biofilms were 
incubated with mouse anti-dsDNA antibody (2 μ g mL–1); this involved 1 h incubation at 4 °C followed by 30 min 
incubation at room temperature in the dark with Alexa fluor 488-labelled goat anti-mouse IgG (1:500) (A-11001, 
Invitrogen) (diluted 1/500). Lectins and CW were incubated for 20 min with 25–80 mg mL−1 of specific sugars or 
polysaccharides at room temperature in the dark to check their binding75. After staining, the biofilms were gently 
rinsed with 0.5 ml PBS. Observations were made at a 63× magnification using a Leica TCS-SP2-AOBS-UV CLSM 
equipped with an argon ion laser. Images were analyzed using LCS software from Leica. Projections were obtained 
in the planes x–y (individual scans at 0.5 μ m intervals) and x–z (images at 6 μ m intervals).
Analysis of extracellular and cell surface-associated glycans. EPS were prepared by growing NTHi 
54997 in 50 Petri dishes (10 cm diameter), each containing 20 mL of s(C+ Y) medium, at 37 °C for 6 h under 5% 
CO2 without shaking, or in 1 L of the same medium under planktonic (P) conditions, i.e., in a culture flask. The 
non-adherent cells in the dishes (BP) were pipetted off and the biofilm-grown cells (B) suspended in 20 mM 
sodium phosphate buffer, pH 7.0. The cells were then treated with NaOH (1 M, final concentration) as described 
elsewhere31. In short, alkali-soluble (AS) and alkali-insoluble (AI) fractions were dialyzed using membranes with 
a molecular mass cut-off of 3.5 kDa (SnakeSkin™ Pleted Dialysis Tubing; Thermo Scientific) and the different 
products were freeze-dried. To determine their monosaccharide composition, the AS and AI fractions were 
acid-hydrolyzed. The products were reduced with sodium borohydride and the corresponding alditols acetylated. 
Identification and quantification were performed by gas-liquid chromatography-mass spectrometry (GC-MS). 
For quantification, myo-inositol (100 μ g) was used as an internal standard. To analyze the bonding between the 
monosaccharide components, 1–3 mg of the AI and AS fractions were permethylated, hydrolyzed and converted 
into a mixture of partially methylated alditol acetates that was analyzed by GC-MS. Quantifications were made 
according to the peak area.
Statistical analysis. Data comparisons were performed using the two-tailed Student t-test.
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